Filing Details
ANGIODYNAMICS INC (NASDAQ:ANGO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 08, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ANGO
ANGIODYNAMICS INC (ANGO) Files Quarterly Report for Q0
ANGIODYNAMICS INC (NASDAQ:ANGO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 08, 2026.
At publication ·
What changed
ANGIODYNAMICS INC (NASDAQ:ANGO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- AngioDynamics Inc filed its quarterly report (Form 10-Q) with the SEC on October 8, 2026.
- The company's stock trades at $11.23 with a market capitalization of $471.5 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance.
Market Context
ANGIODYNAMICS INC's stock currently trades at $11.23 with a market capitalization of $471.5M.
The 10-Q provides ANGIODYNAMICS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for ANGIODYNAMICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ANGO Stock Page
Frequently Asked Questions
Where can I read ANGO's SEC filings?
Browse all filings on our ANGO SEC filings page.
What types of SEC filings does ANGIODYNAMICS INC file?
Public companies like ANGIODYNAMICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.